Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

The Characteristics and Obstetric Outcomes of Type II Vasa Previa: Systematic Review and Meta-Analysis

View through CrossRef
Vasa previa is a rare fetal life-threatening obstetric disease classified into types I and II. This study aimed to examine the characteristics and obstetric outcomes of type II vasa previa. A systematic review was performed, and 20 studies (1998–2022) were identified. The results from six studies showed that type II vasa previa accounted for 21.3% of vasa previa cases. The characteristics and obstetric outcomes (rate of assisted reproductive technology (ART), antenatal diagnosis, emergent cesarean delivery, maternal transfusion, gestational age at delivery, and neonatal mortality) were compared between type I and II vasa previa, and all outcomes of interest were similar. The association between ART and abnormal placenta (bilobed placenta or succenturiate lobe) was examined in three studies, and the results were as follows: (i) increased rate of succenturiate lobes (ART versus non-ART pregnancy; OR (odds ratio) 6.97, 95% confidence interval (CI) 2.45–19.78); (ii) similar rate of abnormal placenta (cleavage-stage versus blastocyst embryo transfer); (iii) increased rate of abnormal placenta (frozen versus fresh embryo transfer; OR 2.97, 95%CI 1.10–7.96). Although the outcomes of type II vasa previa appear to be similar to those of type I vasa previa, the current evidence is insufficient for a robust conclusion.
Title: The Characteristics and Obstetric Outcomes of Type II Vasa Previa: Systematic Review and Meta-Analysis
Description:
Vasa previa is a rare fetal life-threatening obstetric disease classified into types I and II.
This study aimed to examine the characteristics and obstetric outcomes of type II vasa previa.
A systematic review was performed, and 20 studies (1998–2022) were identified.
The results from six studies showed that type II vasa previa accounted for 21.
3% of vasa previa cases.
The characteristics and obstetric outcomes (rate of assisted reproductive technology (ART), antenatal diagnosis, emergent cesarean delivery, maternal transfusion, gestational age at delivery, and neonatal mortality) were compared between type I and II vasa previa, and all outcomes of interest were similar.
The association between ART and abnormal placenta (bilobed placenta or succenturiate lobe) was examined in three studies, and the results were as follows: (i) increased rate of succenturiate lobes (ART versus non-ART pregnancy; OR (odds ratio) 6.
97, 95% confidence interval (CI) 2.
45–19.
78); (ii) similar rate of abnormal placenta (cleavage-stage versus blastocyst embryo transfer); (iii) increased rate of abnormal placenta (frozen versus fresh embryo transfer; OR 2.
97, 95%CI 1.
10–7.
96).
Although the outcomes of type II vasa previa appear to be similar to those of type I vasa previa, the current evidence is insufficient for a robust conclusion.

Related Results

Evaluating the Science to Inform the Physical Activity Guidelines for Americans Midcourse Report
Evaluating the Science to Inform the Physical Activity Guidelines for Americans Midcourse Report
Abstract The Physical Activity Guidelines for Americans (Guidelines) advises older adults to be as active as possible. Yet, despite the well documented benefits of physical activi...
Core Outcome Set and Reporting Checklist for Studies on Vasa Previa
Core Outcome Set and Reporting Checklist for Studies on Vasa Previa
Importance Vasa previa, although a rare condition affecting 0.46 per 1000 pregnancies, results in high rates of fetal and neonatal mortality and morbidity. Wide...
Validation of Wet and Dry Drug Collection Principle in the Preparation of Vasa Ghrita Through Quantitative Estimation of Vasicine
Validation of Wet and Dry Drug Collection Principle in the Preparation of Vasa Ghrita Through Quantitative Estimation of Vasicine
Principle of wet and dry drug collection is applied for collection of drugs while preparing any formulations i.e. wet state of drug is taken in double to its dry drug quantity but ...
Obstetric and Perinatal Outcomes in Pregnancies Complicated by Placenta Previa and Placental Abruption
Obstetric and Perinatal Outcomes in Pregnancies Complicated by Placenta Previa and Placental Abruption
Antepartum hemorrhage is a grave and potentially life-threatening condition and a major cause of both maternal and fetal mortality. The study aims to compare the fetal and maternal...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract Introduction Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...
Risk Factors and Perinatal Outcomes for Placenta Praevia at Delivery in nulliparas: a Retrospective Case-control Study
Risk Factors and Perinatal Outcomes for Placenta Praevia at Delivery in nulliparas: a Retrospective Case-control Study
Abstract Background Placenta previa leads to dangerous obstetrical outcomes, including obstetrical hemorrhage and preterm birth, and its rate is still increasing.T...
Obstetric admission and maternal mortality in the intensive care unit in Africa: A systematic review and meta-analysis
Obstetric admission and maternal mortality in the intensive care unit in Africa: A systematic review and meta-analysis
Background Obstetric complications are a major contributor to maternal morbidity and mortality worldwide, especially in low-resource settings such as many countries in Africa. Inte...

Back to Top